Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: A long-term follow-up

By Olinder-Nielsen Ann-Margreth   Granert Carl   Forsberg Pia   Friman Vanda   Vietorisz Auli   Björkander Janne  

Scandinavian Journal of Infectious Diseases, Vol. 39, Iss. 1, 2007-01 ,pp. : 44-50

Informa Healthcare

Access to resources Recommend Favorite

Life‐threatening bleeding in factor VII deficiency: the role of prenatal diagnosis and primary prophylaxis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 3, 2015-02 ,pp. : 452-455

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on‐demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 320-329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Japanese family with congenital factor VII deficiency

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 5, 2015-10 ,pp. : 1023-1024

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight®) in previously treated patients with severe haemophilia A: interim results of the guardian™2 extension trial

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : e436-e439

John Wiley & Sons Inc

Access to resources Recommend Favorite